Characteristics of patients preferring once-daily controller therapy for asthma and copd: A retrospective cohort study

Primary Care Respiratory Journal

Volumn 22, Issue 2, 2013, Pages 161-168

  Price, David ^a,b   Lee, Amanda J ^a   Sims, Erika J ^b,c   Kemp, Linda ^b   Hillyer, Elizabeth V ^b   Chisholm, Alison ^b   Von Ziegenweidt, Julie ^b   Williams, Angela ^d  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b Research in Real Life   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Adherence; Asthma; Chronic obstructive pulmonary disease; Once daily; Preference; Retrospective observational study

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; SHORT ACTING DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CHILD; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; INHALER; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT CARE; PATIENT COMPLIANCE; PATIENT PREFERENCE; PRESCHOOL CHILD; QUESTIONNAIRE; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT PREFERENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84878513998     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2013.00017     Document Type: Article

References (36)

1. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization, 2003
2. Cutler DM, Everett W. Thinking outside the pillbox-medication adherence as a priority for health care reform. N Engl J Med 2010;362(17):1553-5. http://dx.doi.org/10.1056/NEJMp1002305
3. Hasford J, Uricher J, Tauscher M, Bramlage P, Virchow JC. Persistence with asthma treatment is low in Germany especially for controller medication: a population based study of 483,051 patients. Allergy 2010;65(3):347-54. http://dx.doi.org/10.1111/j.1398-9995.2009.02161.x
4. Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben-Joseph RH. Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest 2000;117(2):542-50. http://dx.doi.org/10.1378/chest.117.2.542
5. Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax 2008;63(9):831-8. http://dx.doi.org/10.1136/thx.2007.086041
6. Charles MS, Blanchette CM, Silver H, Lavallee D, Dalal AA, Mapel D. Adherence to controller therapy for chronic obstructive pulmonary disease: a review. Curr Med Res Opin 2010;26(10):2421-9. http://dx.doi.org/10.1185/03007995.2010.516284
7. Barnes PJ, Jonsson B, Klim JB. The costs of asthma. Eur Respir J 1996;9(4):636-42. http://dx.doi.org/10.1183/09031936.96.09040636
8. Bahadori K, Doyle-Waters MM, Marra C, et al. Economic burden of asthma: a systematic review. BMC Pulm Med 2009;9:24. http://dx.doi.org/10.1186/1471-2466-9-24
9. George J, Kong DC, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest 2005;128(5):3198-204. http://dx.doi.org/10.1378/chest.128.5.3198
10. Dalal AA, Shah M, D'Souza AO, Rane P. Costs of COPD exacerbations in the emergency department and inpatient setting. Respir Med 2011;105(3):454-60. http://dx.doi.org/10.1016/j.rmed.2010.09.003
11. Haughney J, Price D, Kaplan A, et al. Achieving asthma control in practice: understanding the reasons for poor control. Respir Med 2008;102(12):1681-93. http://dx.doi.org/10.1016/j.rmed.2008.08.003
12. Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest 2006;130(1 Suppl):65S-72S. http://dx.doi.org/10.1378/chest.130.1_suppl.65S
13. Horne R, Price D, Cleland J, et al. Can asthma control be improved by understanding the patient's perspective? BMC Pulm Med 2007;7:8. http://dx.doi.org/10.1186/1471-2466-7-8
14. Papi A, Haughney J, Virchow JC, Roche N, Palkonen S, Price D. Inhaler devices for asthma: a call for action in a neglected field. Eur Respir J 2011;37(5):982-5. http://dx.doi.org/10.1183/09031936.00150910
15. Vincken W, Dekhuijzen PR, Barnes P. The ADMIT series - Issues in inhalation therapy. 4) How to choose inhaler devices for the treatment of COPD. Prim Care Respir J 2010;19(1):10-20. http://dx.doi.org/10.4104/pcrj.2009.00062
16. Price D, Musgrave SD, Shepstone L, et al. Leukotriene antagonists as first-line or addon asthma-controller therapy. N Engl J Med 2011;364(18):1695-707. http://dx.doi.org/10.1056/NEJMoa1010846
17. Price D, Robertson A, Bullen K, Rand C, Horne R, Staudinger H. Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study. BMC Pulm Med 2010;10:1. http://dx.doi.org/10.1186/1471-2466-10-1
18. Optimum Patient Care. http://www.optimumpatientcare.org/ (accessed August 2012).
19. Juniper EF, Svensson K, Mork AC, Stahl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med 2005;99(5):553-8. http://dx.doi.org/10.1016/j.rmed.2004.10.008
20. Juniper EF, Bousquet J, Abetz L, Bateman ED. Identifying 'well-controlled' and 'not well-controlled' asthma using the Asthma Control Questionnaire. Respir Med 2006;100(4):616-21. http://dx.doi.org/10.1016/j.rmed.2005.08.012
21. National Clinical Guideline Centre. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. CG101. London: National Clinical Guideline Centre, 2010. http://guidance.nice.org.uk/CG101/Guidance/pdf/English (accessed August 2012).
22. National Clinical Guideline Centre. Chronic obstructive pulmonary disease: management of chronic obstructive pulmonary disease in adults in primary and secondary care. CG12. London: National Clinical Guideline Centre, 2004. http://guidance.nice.org.uk/CG12 (accessed August 2012).
23. Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD). Global Strategy for Diagnosis, Management, and Prevention of COPD. http://www.goldcopd.org/ (accessed August 2012).
24. Clinical COPD Questionnaire. http://www.ccq.nl/ (accessed August 2012).
25. Jones PW, Price D, van der Molen T. Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2011;6:289-96. http://dx.doi.org/10.2147/COPD.S18181
26. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes 2003;1:13. http://dx.doi.org/10.1186/1477-7525-1-13
27. Fletcher CM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959;2(5147):257-66. http://dx.doi.org/10.1136/bmj.2.5147.257
28. Stenton C. The MRC breathlessness scale. Occup Med (Lond) 2008;58(3):226-7. http://dx.doi.org/10.1093/occmed/kqm162
29. Horne R, Weinman J, Hankins M. The Beliefs about Medicines Questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1999;14(1):1-24. http://dx.doi.org/10.1080/08870449908407311
30. Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health 2002;17(1):17-32. http://dx.doi.org/10.1080/08870440290001502
31. Clatworthy J, Price D, Ryan D, Haughney J, Horne R. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J 2009;18(4):300-5. http://dx.doi.org/10.4104/pcrj.2009.00037
32. Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med 2008;31(3):213-24. http://dx.doi.org/10.1007/s10865-007-9147-y
33. Conn KM, Halterman JS, Lynch K, Cabana MD. The impact of parents' medication beliefs on asthma management. Pediatrics 2007;120(3):e521-6. http://dx.doi.org/10.1542/peds.2006-3023
34. Menckeberg TT, Bouvy ML, Bracke M, et al. Beliefs about medicines predict refill adherence to inhaled corticosteroids. J Psychosom Res 2008;64(1):47-54. http://dx.doi.org/10.1016/j.jpsychores.2007.07.016
35. Ponieman D, Wisnivesky JP, Leventhal H, Musumeci-Szabo TJ, Halm EA. Impact of positive and negative beliefs about inhaled corticosteroids on adherence in inner-city asthmatic patients. Ann Allergy Asthma Immunol 2009;103(1):38-42. http://dx.doi.org/10.1016/S1081-1206(10)60141-X
36. van Grunsven PM, van Schayck CP, van Deuveren M, van Herwaarden CL, Akkermans RP, van Weel C. Compliance during long-term treatment with fluticasone propionate in subjects with early signs of asthma or chronic obstructive pulmonary disease (COPD): results of the Detection, Intervention, and Monitoring Program of COPD and Asthma (DIMCA) Study. J Asthma 2000;37(3):225-34. http://dx.doi.org/10.3109/ 02770900009055445